Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 8623466)

Published in Transplant Proc on April 01, 1996

Authors

R E Bullingham1, A Nicholls, M Hale

Author Affiliations

1: Roche Bioscience, Palo Alto, California 94303, USA.

Articles citing this

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood (2005) 1.27

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant (2010) 1.03

Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9. Br J Clin Pharmacol (2008) 0.99

Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transplant (2008) 0.98

Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. Br J Clin Pharmacol (2003) 0.95

Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. Eur J Clin Pharmacol (2005) 0.91

Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors. Br J Clin Pharmacol (2013) 0.87

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br J Clin Pharmacol (2005) 0.85

A review on therapeutic drug monitoring of immunosuppressant drugs. Iran J Basic Med Sci (2011) 0.83

Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83

Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation. Br J Clin Pharmacol (2010) 0.82

No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation. Eur J Clin Pharmacol (2009) 0.81

Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy. Br J Clin Pharmacol (2010) 0.79

The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients. Eur J Clin Pharmacol (2010) 0.78

Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models. BMC Cardiovasc Disord (2005) 0.78

Clinical mycophenolic acid monitoring in liver transplant recipients. World J Gastroenterol (2014) 0.76

Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients. J Zhejiang Univ Sci B (2005) 0.76

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clin Exp Gastroenterol (2015) 0.75

Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine. Clin Exp Nephrol (2016) 0.75

Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus. J Pharm Health Care Sci (2017) 0.75

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. Pediatr Nephrol (2016) 0.75

Articles by these authors

Classical electrostatics in biology and chemistry. Science (1995) 17.26

Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99

Elective ventilation of potential organ donors. BMJ (1995) 5.50

Reiter's disease and HL-A 27. Lancet (1973) 4.10

Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03

Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet (1992) 3.80

Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science (1991) 3.79

Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74

Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models. Biochemistry (1991) 2.46

Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem (1984) 2.25

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11

Free-energy determinants of alpha-helix insertion into lipid bilayers. Biophys J (1996) 1.89

Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88

Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr D Biol Crystallogr (2006) 1.84

HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet (1974) 1.68

Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68

Deregulation of mouse antibody-forming cells in vivo in cell culture by streptococcal pyrogenic exotoxin. Infect Immun (1975) 1.60

The spectrum of HIV-1 related cancers in South Africa. Int J Cancer (2000) 1.58

The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52

High or low osmolar contrast media? Clin Radiol (1991) 1.37

Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans. Br J Cancer (2002) 1.30

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol (1996) 1.29

Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta. Proc Natl Acad Sci U S A (1984) 1.29

Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29

Organ donation. BMJ (1993) 1.27

Ethics and elective ventilation. Br J Hosp Med (1994) 1.25

Effect of weight-loss on plasma and urinary levels of uric acid. Lancet (1972) 1.25

Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23

Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene (1995) 1.12

Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms. J Biol Chem (1986) 1.11

MRI phase mapping of temperature distributions induced in food by microwave heating. Magn Reson Imaging (2000) 1.02

Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01

Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01

Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans. Br J Cancer (2008) 1.01

Adenoid cystic carcinoma of the salivary glands: a review of 10 years. Laryngoscope (1997) 1.00

The Gaussian Generalized Born model: application to small molecules. Phys Chem Chem Phys (2007) 0.97

Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control study. Infect Agent Cancer (2006) 0.96

Letter: Acute anterior uveitis and HL-A 27. Lancet (1974) 0.94

Perceived numerosity as a function of item size. Percept Mot Skills (1988) 0.93

Dramatic decrease in tuberculin skin test conversion rate among employees at a hospital in New York City. Am J Infect Control (1995) 0.91

Tuberculosis in children dying with HIV-related lung disease: clinical-pathological correlations. Int J Tuberc Lung Dis (2002) 0.91

The arthropathy of the Muckle-Wells syndrome. Br J Rheumatol (1994) 0.90

Chlamydia trachomatis and infertility. Lancet (1986) 0.90

Rectal manifestations of pellagra. Int J Colorectal Dis (1986) 0.90

Determinants of the first decade of bone loss after menopause at spine, hip and radius. QJM (1999) 0.88

Comparison of the growth of the Ehrlich ascites tumor in male and female mice. Cancer Res (1967) 0.87

Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency. Ann Rheum Dis (1975) 0.87

A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation (1999) 0.86

Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with varying degrees of hepatic oxidative impairment. J Clin Pharmacol (1996) 0.86

Rat gastric acid secretion in response to graded subcutaneous doses of 2-deoxy-D-glucose. Am J Physiol (1966) 0.85

Allopurinol interaction with cyclosporin. BMJ (1994) 0.85

Medical clearance: fact or fiction in the hospital emergency room. Psychosomatics (1990) 0.84

Ocular and renal sarcoidosis. J R Soc Med (1995) 0.83

The prolonged course of gastrointestinal tuberculosis. J Clin Gastroenterol (1989) 0.82

Low socioeconomic status and risk for infection with human herpesvirus 8 among HIV-1 negative, South African black cancer patients. Epidemiol Infect (2004) 0.82

Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women. Calcif Tissue Int (1995) 0.81

The source of a gastric secretory inhibitor from human saliva. Australas Ann Med (1968) 0.81

Lymphocyte-specific genetic instability and cancer. Cold Spring Harb Symp Quant Biol (1994) 0.81

A human DEAD box protein with partial homology to heterogeneous nuclear ribonucleoprotein U. Gene (1994) 0.81

Case report: accessory lobe of the liver mimicking lesser omental lymphadenopathy. Br J Radiol (1993) 0.81

Indium (111In)-labelled platelets in the diagnosis of renal transplant rejection: preliminary findings. Br J Radiol (1981) 0.80

Accuracy of survey radiographic diagnosis of intervertebral disc protrusion in dogs. Vet Radiol Ultrasound (2002) 0.79

Plasma exchange in acute renal allograft rejection: is a controlled trial really necessary? Transplantation (1981) 0.79

What our patients are reading about reproductive technologies. A review of eight popular women's magazines, 1978 and 1988. Birth Defects Orig Artic Ser (1990) 0.79

Inhibition of gastric acid secretion by a purified bacterial lipopolysaccharide. Nature (1967) 0.79

Blood volume in malignant disease: case studies in 86 females. Aust N Z J Surg (1968) 0.78

The temporomandibular joint pain-dysfunction syndrome: a frequent cause of headache. Headache (1981) 0.78

Resource needs of an occupational health service to accommodate a hepatitis B vaccination programme. J Soc Occup Med (1990) 0.78

Toxicity of folic acid. Lancet (1970) 0.78

Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J (Clin Res Ed) (1982) 0.77

Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl (1991) 0.77

Automatic analysis of pacemaker diagnostic data in the identification of atrial tachyarrhythmias in patients with no prior history of them. Europace (2005) 0.77

The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol (1981) 0.77

Ehlers-Danlos syndrome type I: a clinical and ultrastructural study of a family with reduced amounts of collagen type III. Br J Dermatol (1987) 0.77

Role of ultrasound in the diagnosis of liver metastases before surgery for large bowel cancer. Br J Surg (1987) 0.76

Long-term evaluation of naproxen suspension in juvenile chronic arthritis. Curr Med Res Opin (1982) 0.76

Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis (1973) 0.75

p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary. Histopathology (2008) 0.75

Effect of stilboestrol on levels of uric acid in plasma and urine. Ann Rheum Dis (1973) 0.75

Ethylene oxide and anaphylaxis during haemodialysis. Br Med J (Clin Res Ed) (1986) 0.75

Search for mycoplasma in synovial fluids from patients with rheumatoid arthritis. Ann Rheum Dis (1974) 0.75

Elective ventilation is cost effective and humane. BMJ (1995) 0.75

Treatment of pulmonary aspergillosis with di-iodohydroxyquinoline. Thorax (1977) 0.75

Long-term dobutamine in heart failure. Postgrad Med J (1994) 0.75

Effect of weight reduction on levels of uric acid in plasma and urine. Ann Rheum Dis (1973) 0.75

Treatment of end stage renal disease. Br Med J (Clin Res Ed) (1984) 0.75

Cost-utility analysis. BMJ (1993) 0.75

Proceedings: Histocompatibility antigen (HL-A 27) and its relation to disease. Ann Rheum Dis (1974) 0.75

Search for mycoplasma in synovial fluids from patients with rheumatoid arthritis. Ann Rheum Dis (1973) 0.75

Establishment of the hematopoietic microenvironment in the marrow of matrix-induced endochondral bone. Exp Hematol (1984) 0.75

Virilization superimposed on Turner's syndrome: cytogenetic studies of a gonadal tumor in a patient with XO-XY mixed gonadal dysgenesis. South Med J (1973) 0.75

On continuing education. Imprint (1982) 0.75

Interdisciplinary education fosters integration/collaboration. Imprint (1982) 0.75

Obituary: A.P. Booth MD, MB, BS, FRCR, DMRE. Clin Radiol (1978) 0.75

Psychiatric complications in a surgical ICU. Crit Care Med (1977) 0.75

Epidemiology of increased lead exposure among 954 one to five-year-old Hartford, Connecticut, Children--1970. Conn Med (1971) 0.75

Pathological effects of pellagra on the esophagus. Nutr Cancer (1990) 0.75

New R.N. examination in '83. Imprint (1981) 0.75